DOROTY DEVALON: Open Payments
NPI 1629544234 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 66 payments from 13 companies in 2025. Trend: 2023 $110 · 2024 $551 · 2025 $1,797
Food & beverage: $1,525Travel & lodging: $272
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $700 |
| ABBVIE INC. | 15 | $322 |
| IBSA Pharma Inc. | 12 | $214 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $155 |
| Collegium Pharmaceutical, Inc. | 7 | $109 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $76 |
| SPR Therapeutics, Inc | 5 | $52 |
| Saluda Medical Americas, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Globus Medical, Inc. | 2 | $33 |
Products named: PROCLAIM, QULIPTA, Tirosint, RELISTOR, Belbuca, JOURNAVX, UBRELVY, SPRINT PNS System.
Industry payments across IL — which companies pay providers there.
